Eagle Pharmaceuticals competitorsClear all

Eagle Pharmaceuticals's top competitors include NeuroVive Pharmaceutical, Acousia Therapeutics, Y-mAbs Therapeutics and Vidac Pharma.
Eagle Pharmaceuticals
Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas.
NeuroVive Pharmaceutical
NeuroVive Pharmaceutical
NeuroVive Pharmaceutical engages in the research and development of mitochondrial medicine.
Acousia Therapeutics
Acousia Therapeutics
Acousia Therapeutics is a biotech company working to identify small molecules for treatment of hearing loss.
Y-mAbs Therapeutics
Y-mAbs Therapeutics
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
Vidac Pharma
Vidac Pharma
Vidac Pharma is a biopharmaceutical company that develops medicines for the treatment of oncologic and dermatologic diseases.
Founding Date
Founding Date
2007
Founding Date
2000
Founding Date
2017
Founding Date
2014
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Woodcliff Lake, US HQ
Chicago, US
Locations
Lund, SE HQ
Locations
Tübingen, DE HQ
Locations
New York, US HQ
Rungsted Kyst, DK
Locations
Jerusalem, IL HQ
Brookline, US
Employees
Employees
9611% decrease
Employees
10
Employees
N/A
Employees
3239% increase
Employees
118% decrease
Valuation ($)
Valuation ($)
695.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
777.2 m
Valuation ($)
N/A
Twitter followers
Twitter followers
19
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
39
Alexa Website Rank
Alexa Website Rank
587706
Alexa Website Rank
1516374
Alexa Website Rank
472961
Alexa Website Rank
1026148
Alexa Website Rank
N/A

Financial

Net income
Net income
$31.9m (FY, 2018)
Net income
N/A
Net income
N/A
Net income
($43.3m) (FY, 2018)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 12m (over 1 year ago)
Latest funding round
N/A
Latest funding round
$ 9m (over 3 years ago)
Total funding raised
Total funding raised
$ 12.3m
Total funding raised
$ 10.8m
Total funding raised
$ 14.6m
Total funding raised
$ 80m
Total funding raised
$ 9m
For sources of this data, please see the company profile

View company profiles

NeuroVive Pharmaceutical
HQ
Lund, SE
Employees
10

NeuroVive Pharmaceutical engages in the research and development of mitochondrial medicine.

View company
Acousia Therapeutics
HQ
Tübingen, DE

Acousia Therapeutics is a biotech company working to identify small molecules for treatment of hearing loss.

View company
Y-mAbs Therapeutics
HQ
New York, US
Employees
32↑ 39% increase

Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.

View company
Vidac Pharma
HQ
Jerusalem, IL
Employees
11↓ 8% decrease

Vidac Pharma is a biopharmaceutical company that develops medicines for the treatment of oncologic and dermatologic diseases.

View company